Table 1.
Demographics and laboratory characteristics in the study groups
| HC (n=40) | RA (n=64) | BD (n=49) | p | |
|---|---|---|---|---|
| Sex (F/M) | 11/29 | 13/51 | 21/28 | 0.001b |
| Age (years) | 43.5±13.5 | 50.3±15.1* | 37.3±11.2††† | <0.001a |
| BMI (kg /m2) | 26.8±4.9 | 27.2±5.5 | 26.5±4.4 | 0.764a |
| ESR (mm/h) | 16.3±10.9 | 33.8±23.7*** | 23.1±21.8† | <0.001a |
| CRP (mg/dL) | 0.31±0.32 | 2.46±3.65** | 1.37±2.23 | 0.002a |
| WBC (103/μL) | 6.5±1.5 | 7.3±2.3 | 7.2±2.2 | 0.174a |
| Hb (g/dL) | 13.8±1.4 | 12.3±1.7*** | 13.4±1.5†† | <0.001a |
| PLT (103/μL) | 266.8±68.7 | 294.3±9.8 | 260.4±77.3 | 0.083a |
| Total cholesterol (mg/dL) | 190.7±53.2 | 168.9±35.2 | 173.3±51.8 | 0.059a |
| Triglycerides (mg/dL) | 147.5±90.1 | 99.9±47.8* | 145.4±125.7† | 0.008a |
| LDL (mg/dL) | 136.8±46.2 | 110.2±31.1** | 113.0±47.2† | 0.004a |
| HDL (mg/dL) | 50.2±14.0 | 50.4±13.5 | 50.6±17.2 | 0.994a |
| Smoking, n (%) | 10 (25) | 21 (32) | 8 (16) | 0.670b |
| HT, n (%) | 8 (20) | 21 (32) | 8 (16) | 0.029b |
| DM, n (%) | 1 (2) | 9 (14) | 1 (2) | 0.018b |
| CAD, n (%) | 0 | 2 (4) | 1 (2) | 0.425b |
HC: healthy control; RA: rheumatoid arthritis; BD: Behçet’s disease; F: female; M: male; BMI: Body Mass Index; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; WBC: white blood cell; Hb: hemoglobin; PLT: platelet; LDL: low-density lipoprotein cholesterol; HDL: high-density lipoprotein cholesterol: HT: hypertension; DM: diabetes mellitus; CAD: coronary artery disease
Data were expressed as mean±standard deviation.
a
ANOVA and
b
chi-square p-values.
When compared to the HC group;
*
p<0.05,
**
p<0.01,
***
p<0.001.
When compared to the RA group;
†
p<0.05,
††
p<0.01,
†††
p<0.001.